Project title: BIODEGRADABLE BALLOONS FOR TISSUE SEPARATION

Company name : BIOPROTECT LTD.

TECHNOLOGICAL FIELD
Medical devices

KEY WORDS
Cancer, Radiotherapy,
Orthopedics, Biodegradable, Implant, Balloon, Catheter, Prostate

PROJECT SUMMARY
BioProtect devices are a family of patent-protected biodegradable
biological implants that are introduced by minimally invasive
procedures at the desired location under the guidance of US, CT,
MRI, fluoroscopy, laparoscopy, or left in place at the end of a
surgical intervention.

BioProtect's first product (SpaceGuard Balloon) is indicated for
prostate cancer patients undergoing radiotherapy treatments. The
implant separates the prostate from healthy tissues and organs
surrounding the prostate (i.e. rectum, erectile nerve bundles)
and thereby minimizes the applied radiation to these organs. The
implant is designed to dissolve after 3-6 months, corresponding
to the standard duration of radiotherapy procedures for prostate
cancer. The implant is made of well known biodegradable material
routinely used in existing medically approved devices (such as
pericardial patch). The balloon insertion technique is based on a
well-established technique commonly used by urologists at
outpatient centers.

BioProtect's second product (ShoulderGuard Balloon) is indicated
for the treatment of patients suffering from shoulder pain due to
tears of rotator cuff tendon. BioProtect's orthopedic implant
separates the injured tendon from the bone, eliminates the cause
of injury and allows fast and painless tendon full recovery. The
balloon can be implanted at the doctor's office and is designed
to dissolve after 3 months, corresponding to the duration
required for the tendon to recover.

BioProtect is also developing a solution for slow drug release
using its platform. The balloon can be used for both systemic and
localized drug delivery. Systemically, the device can be used as
a delivery solution for unstable hormones like: Growth Hormone,
Erythropoietin and many more. When used locally, the device can
be used as a complementary treatment for the specific balloon
application.

ENTREPRENEURS
Mr. Shaul Shohat - General Manager, M.Sc in Analytical
Chemistry, experience in development of medical devices.
Dr. Adrian Paz - Senior Consultant, MD, Chief of the
urological laparoscopic services at Barzilai Medical Center,
Ashkelon.
Prof. Abraham Domb - Senior Consultant, PhD, Professor,
Chairman: Dept. Medicine Chemistry and Natural Products. School
of Pharmacy- Faculty of Medicine, the Hebrew University of
Jerusalem.

PROJECT STATUS
BioProtect completed the development of the device for prostate
cancer and completed all required pre-clinical studies.
Human trials for the product are expected to start in Q3 2007 at
the Souraski Medical Center in Tel Aviv

COOPERATION REQUIRED
BioProtect is currently looking for Beta-sites in Israeli and US
hospitals.

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about